Diril, M. Et Al. 2023. In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma. Pharmaceutical Development and Technology , vol.28, no.10 , 915-927.

Diril, M., ÖZDOKUR, K. V., YILDIRIM, Y., & KARASULU, H. Y., (2023). In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma. Pharmaceutical Development and Technology , vol.28, no.10, 915-927.

Diril, Mine Et Al. "In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma," Pharmaceutical Development and Technology , vol.28, no.10, 915-927, 2023

Diril, Mine Et Al. "In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma." Pharmaceutical Development and Technology , vol.28, no.10, pp.915-927, 2023

Diril, M. Et Al. (2023) . "In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma." Pharmaceutical Development and Technology , vol.28, no.10, pp.915-927.

@article{article, author={Mine Diril Et Al. }, title={In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma}, journal={Pharmaceutical Development and Technology}, year=2023, pages={915-927} }